Drug intelligence / Profile preview

α-13'-COOH

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical
01

Overview

α-13'-COOH, also known as α-13'-carboxychromanol, is a long-chain metabolite of α-tocopherol (vitamin E) formed through enzymatic degradation in the liver. It is detected in human serum, indicating its systemic bioavailability. This molecule exhibits a range of biological activities distinct from its precursor, including anti-inflammatory, anti-proliferative, and anti-atherogenic effects. It has shown chemopreventive potential in colon adenoma cells, anti-inflammatory properties in atopic dermatitis skin models, and accelerates wound healing in mouse models. Its mechanism of action involves modulating cytokine expression, affecting macrophage foam cell formation, and influencing pathways like MAPK and NFκB. It also impacts lipid metabolism and can induce P-glycoprotein expression.

Other names
α-13'-carboxychromanol13'-carboxychromanol
02

Targets

PXR (Pregnane X receptor)ANGPTL4 (Angiopoietin-like 4)CCL2 (C-C motif chemokine 2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MAPK3 (Mitogen-activated protein kinase 1)NOS2 (Nitric Oxide Synthase 2)IL1B (Interleukin-1 beta)IL10 (Interleukin-10)IL-6 (Interleukin 6)PLIN2 (Perilipin-2)LPL (Lipoprotein lipase)MEKNF-κBABCB1 (P-glycoprotein)TNFA (Tumor necrosis factor alpha (soluble))MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on α-13'-COOH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α-13'-COOH.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call